Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Rang în acțiuni #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Preț acțiune
$0.12164306
Ultima sincronizare: 2024-11-11
Capitalizare de piață
$38.53M
Schimbare (1 zi)
-4.14%
Schimbare (1 an)
0.00%
Țară
AU
Tranzacționează PharmAust Limited (PAA)

Categorie

Istoric al prețului acțiunii pentru PharmAust Limited (PAA)
Cel mai mare preț de închidere: $0.12 pe 2024-11-01

Cel mai mic preț de închidere: $3.11 pe 2001-10-01
Istoric al prețului acțiunii pentru PharmAust Limited din 2001 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2024 72.79%
2023 61.50%
2022 -33.17%
2021 -20.54%
2020 20.68%
2019 171.67%
2018 -30.35%
2017 4.90%
2016 -29.98%
2015 -55.93%
2014 -33.04%
2013 25.44%
2012 -54.31%
2011 -8.75%
2010 -46.71%
2009 152.12%
2008 -65.75%
2007 -55.38%
2006 -27.70%
2005 -34.70%
2004 20.98%
2003 69.43%
2002 -28.84%
2001 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$544.87 38.17%
US
$1.03K 56.37%
NL
$120.74 -14.98%
AU
$139.03 417.03%
US
$762.65 7.15%
CH